Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases.
Saved in:
| Title: | Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases. |
|---|---|
| Authors: | Chia DKA; Department of Surgery, University Surgical Cluster, National University Health System, Singapore, Singapore., Sundar R; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; The N.1 Institute for Health, National University of Singapore, Singapore, Singapore., Kim G; Department of Surgery, University Surgical Cluster, National University Health System, Singapore, Singapore., Ang JJ; Department of Surgery, University Surgical Cluster, National University Health System, Singapore, Singapore., Lum JHY; Department of Pathology, National University Hospital, National University Health System, Singapore, Singapore., Nga ME; Department of Pathology, National University Hospital, National University Health System, Singapore, Singapore., Goh GH; Department of Pathology, National University Hospital, National University Health System, Singapore, Singapore., Seet JE; Department of Pathology, National University Hospital, National University Health System, Singapore, Singapore., Chee CE; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore., Tan HL; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore., Ho J; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore., Ngoi NYL; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore., Lee MXW; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore., Muthu V; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore., Chan GHJ; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore., Pang ASL; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore., Ang YLE; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore., Choo JRE; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore., Lim JSJ; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore., Teh JL; Department of General Surgery, Ng Teng Fong General Hospital, Singapore, Singapore., Lwin A; Department of General Surgery, Ng Teng Fong General Hospital, Singapore, Singapore., Soon Y; Department of General Surgery, Ng Teng Fong General Hospital, Singapore, Singapore., Shabbir A; Department of Surgery, University Surgical Cluster, National University Health System, Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Division of Surgical Oncology, National University Cancer Institute, National University Health System, Singapore, Singapore., So JBY; Department of Surgery, University Surgical Cluster, National University Health System, Singapore, Singapore. jimmyso@nus.edu.sg.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. jimmyso@nus.edu.sg.; Division of Surgical Oncology, National University Cancer Institute, National University Health System, Singapore, Singapore. jimmyso@nus.edu.sg., Yong WP; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore.; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore. |
| Source: | Annals of surgical oncology [Ann Surg Oncol] 2022 Dec; Vol. 29 (13), pp. 8597-8605. Date of Electronic Publication: 2022 Sep 07. |
| Publication Type: | Clinical Trial, Phase II; Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36070113 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Chia+DKA%22">Chia DKA</searchLink>; Department of Surgery, University Surgical Cluster, National University Health System, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Sundar+R%22">Sundar R</searchLink>; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; The N.1 Institute for Health, National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Kim+G%22">Kim G</searchLink>; Department of Surgery, University Surgical Cluster, National University Health System, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Ang+JJ%22">Ang JJ</searchLink>; Department of Surgery, University Surgical Cluster, National University Health System, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Lum+JHY%22">Lum JHY</searchLink>; Department of Pathology, National University Hospital, National University Health System, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Nga+ME%22">Nga ME</searchLink>; Department of Pathology, National University Hospital, National University Health System, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Goh+GH%22">Goh GH</searchLink>; Department of Pathology, National University Hospital, National University Health System, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Seet+JE%22">Seet JE</searchLink>; Department of Pathology, National University Hospital, National University Health System, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Chee+CE%22">Chee CE</searchLink>; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Tan+HL%22">Tan HL</searchLink>; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Ho+J%22">Ho J</searchLink>; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Ngoi+NYL%22">Ngoi NYL</searchLink>; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Lee+MXW%22">Lee MXW</searchLink>; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Muthu+V%22">Muthu V</searchLink>; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Chan+GHJ%22">Chan GHJ</searchLink>; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Pang+ASL%22">Pang ASL</searchLink>; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Ang+YLE%22">Ang YLE</searchLink>; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Choo+JRE%22">Choo JRE</searchLink>; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Lim+JSJ%22">Lim JSJ</searchLink>; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Teh+JL%22">Teh JL</searchLink>; Department of General Surgery, Ng Teng Fong General Hospital, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Lwin+A%22">Lwin A</searchLink>; Department of General Surgery, Ng Teng Fong General Hospital, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Soon+Y%22">Soon Y</searchLink>; Department of General Surgery, Ng Teng Fong General Hospital, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Shabbir+A%22">Shabbir A</searchLink>; Department of Surgery, University Surgical Cluster, National University Health System, Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Division of Surgical Oncology, National University Cancer Institute, National University Health System, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22So+JBY%22">So JBY</searchLink>; Department of Surgery, University Surgical Cluster, National University Health System, Singapore, Singapore. jimmyso@nus.edu.sg.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. jimmyso@nus.edu.sg.; Division of Surgical Oncology, National University Cancer Institute, National University Health System, Singapore, Singapore. jimmyso@nus.edu.sg.<br /><searchLink fieldCode="AU" term="%22Yong+WP%22">Yong WP</searchLink>; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore.; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229420840%22">Annals of surgical oncology</searchLink> [Ann Surg Oncol] 2022 Dec; Vol. 29 (13), pp. 8597-8605. <i>Date of Electronic Publication: </i>2022 Sep 07. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase II; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9420840 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1534-4681 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210689265%22">10689265 </searchLink><i>NLM ISO Abbreviation: </i>Ann Surg Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36070113 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1245/s10434-022-11998-z Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 8597 Titles: – TitleFull: Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chia DKA – PersonEntity: Name: NameFull: Sundar R – PersonEntity: Name: NameFull: Kim G – PersonEntity: Name: NameFull: Ang JJ – PersonEntity: Name: NameFull: Lum JHY – PersonEntity: Name: NameFull: Nga ME – PersonEntity: Name: NameFull: Goh GH – PersonEntity: Name: NameFull: Seet JE – PersonEntity: Name: NameFull: Chee CE – PersonEntity: Name: NameFull: Tan HL – PersonEntity: Name: NameFull: Ho J – PersonEntity: Name: NameFull: Ngoi NYL – PersonEntity: Name: NameFull: Lee MXW – PersonEntity: Name: NameFull: Muthu V – PersonEntity: Name: NameFull: Chan GHJ – PersonEntity: Name: NameFull: Pang ASL – PersonEntity: Name: NameFull: Ang YLE – PersonEntity: Name: NameFull: Choo JRE – PersonEntity: Name: NameFull: Lim JSJ – PersonEntity: Name: NameFull: Teh JL – PersonEntity: Name: NameFull: Lwin A – PersonEntity: Name: NameFull: Soon Y – PersonEntity: Name: NameFull: Shabbir A – PersonEntity: Name: NameFull: So JBY – PersonEntity: Name: NameFull: Yong WP IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2022 Dec Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1534-4681 Numbering: – Type: volume Value: 29 – Type: issue Value: 13 Titles: – TitleFull: Annals of surgical oncology Type: main |
| ResultId | 1 |
